Technology-Assisted Upper Limb Therapy (TAULT): Evaluation of Clinical Practice at a Specialised Centre for Spinal Cord Injury in Switzerland
Healthcare, 2023 · DOI: 10.3390/healthcare11233055 · Published: November 28, 2023
Simple Explanation
This study evaluates the use of technology-assisted upper limb therapy (TAULT) at a Swiss spinal cord injury rehabilitation center. The study involved a retrospective analysis of clinical data from January 2018 to June 2020. The ArmeoSpring device was the most frequently used device in the study.
Study Duration
January 2018 to June 2020
Participants
61 adults
Evidence Level
Retrospective analysis
Key Findings
- 1The ArmeoSpring was the most frequently used device for TAULT at the SPC.
- 2Most participants trained three times a week for 25 minutes over six weeks.
- 3Targeted functions and activities, as well as strength, have improved over the course of TAULT.
Research Summary
This study retrospectively analyzed the current routine of TAULT at the SPC, goal-setting practice, and whether changes in functioning were observed along with TAULT. The ArmeoSpring was the most frequently used device in a cohort mostly consisting of individuals with cSCI, underlining its broad applicability for similar populations. Over the course of TAULT, targeted functions and activities, as well as strength, have improved.
Practical Implications
Clinical Practice
The study provides insights into the implementation and effectiveness of TAULT in a specialized SCI rehabilitation center.
Goal Setting
The use of scoring grids for functional goals and the proposed ADL goal-setting grid can enhance goal-oriented therapy.
Future Research
Well-controlled trials are needed to provide evidence for TAULT in people with tetraplegia.
Study Limitations
- 1The absence of a control group prevents conclusions regarding the effectiveness of TAULT.
- 2Concomitant spontaneous neurological recovery and the concurrent application of various rehabilitative interventions.
- 3The inclusion of predominantly individuals with SCI from one single rehabilitation centre in Switzerland limits the generalisability of the findings.